NCDs and SDGs #10 and #12: Show Us the Money! How Greater Drug Pricing Transparency Could Fund Innovation and Improve Access to Medicines:
Can you afford to be healthy?
The health and well-being of all global citizens is supported by the United Nations Sustainable Development Goals. However, inequalities – both within and between countries – mean that some individuals are able to access the services and products that encourage health more than others, a fact recognized by SDG 10 (“Reduce inequality within and among countries”), as well as SDG 12 (“Ensure Sustainable Consumption and Production Patterns”). Rising prices have reduced low-income countries' and individuals of low socio-economic status' ability to access many necessary medicines. People living with chronic diseases, who often pay exorbitant prices over long periods of time, are particularly vulnerable to growing costs - but increased drug pricing transparency can help.
Half of the earth’s 7.5 billion people now live in cities. In 2030, McKinsey & Company say this number will rise to 60%. In every country, on every continent, people are migrating to urban centers. In Montréal, where the urban sprawling is one of the highest in Canada, we are witnessing the occurrence of new environmental issues like air pollution, destruction of agricultural zones, and a globally higher energy consumption. These issues have enormous health consequences such as COPD, asthma, obesity and many secondary cancers.